Items tagged with Guidelines
South Africa makes bedaquiline part of its standard recommended treatment regimen for rifampicin-resistant TB (post with simple image)
Global TB CAB welcomes introduction of safer drug for most South Africans with rifampicin-resistant TB; Other countries and the World Health Organization must now follow.
Treatment Action Group welcomes price reductions for TB medicines (post with simple image)
Countries and donors must do more to ensure all people with TB have access; further price reductions for newer medicines required.
WHO announces landmark changes in MDR-TB treatment regimens (post with simple image)
Major improvement in treatment outcomes and quality of life of patients with multidrug-resistant TB (MDR-TB) are expected.
The TB CAB and TAG welcome WHO recommendation of injectable-free regimens for the treatment of RR/MDR-TB (post with simple image)
The WHO, Ministries of Health and Finance, donors, implementers, technical assistance providers, civil society, and communities must work together to ensure rapid implementation.
WHO updates its treatment guidelines for MDR/RR-TB (post with simple image)
The updated WHO treatment guidelines recommend that drug-resistant TB be treated with oral drugs only, including newer, more potent drugs with fewer side effects.
New WHO recommendations to accelerate progress on TB (post with simple image)
WHO issues new guidance to improve treatment of multidrug-resistant TB.
Advocates raise serious concerns about errors in the WHO guidelines for the treatment of drug-resistant TB (post with simple image)
Advocates call on WHO leadership to act immediately and correct specific technical errors in the WHO guidelines for the treatment of drug-resistant TB.
Crisis of confidence in the WHO's ability to produce normative guidance for the treatment of RR-/MDR-TB (post with simple image)
Advocates request an urgent in-person meeting with the WHO leadership to discuss concrete actions to address technical and guideline development process-related issues previously raised.
Public call for individual patient data on treatment of drug-resistant TB (post with simple image)
The World Health Organization issues a public call for individual patients data on rifampicin-resistant and multidrug-resistant TB treatment outcomes.
Update of WHO guidelines on the programmatic management of drug-resistant TB (post with simple image)
End-users (i.e. policy makers; health professionals, including doctors, nurses and educators working in governmental and non-governmental organizations; TB patients) interested in providing comments on the scope of this guideline update are invited to submit their feedback.
Page 9 of 10 · Total posts: 0←First 8 9 10 Last→